Structured evidence table for Rosemary Cognitive Performance Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Rosemary Cognitive Performance Randomized Trial | This study consolidates the evidence based on phytochemicals for cognitive enhancement, highlighting a need for more robust, methodologically sound trials to determine if these natural compounds hold promise in cognitive therapeutics, particularly for populations with cognitive impairments. | 3 | Marsh Alexander (2026) | The efficacy of nutritional phytochemical compounds in improving cognition |
| Rosemary Cognitive Performance Randomized Trial | Accordingly, this review prespecified phytochemicals that meet 3 criteria: long-standing traditional association with cognition, biological plausibility supported by preclinical evidence, and progression into human research or commercial cognitive-health formulations, includingL. | 3 | Marsh Alexander (2026) | The efficacy of nutritional phytochemical compounds in improving cognition |
| Rosemary Cognitive Performance Randomized Trial | While the evidence surrounding green tea and its relevant constituents is relatively well summarized, the impact that other herbs and phytochemical compounds may have on cognition remains to be systematically reviewed. | 3 | Marsh Alexander (2026) | The efficacy of nutritional phytochemical compounds in improving cognition |
| Rosemary Cognitive Performance Randomized Trial | tenuiflorum This study addresses the effectiveness of various naturally occurring molecules in improving cognitive functions in healthy adults. | 3 | Marsh Alexander (2026) | The efficacy of nutritional phytochemical compounds in improving cognition |
| Rosemary Cognitive Performance Randomized Trial | Emerging evidence highlights the therapeutic potential of plant-derived essential oils and fatty acids in modulating neuroinflammatory pathways through multi-target mechanisms. | 4 | Jin Z (2026) | Anti-Neuroinflammation Activity of Essential Oils and Fatty Acids. |
| Rosemary Cognitive Performance Randomized Trial | Neuroinflammation plays a pivotal role in the pathogenesis of neurodegenerative disorders, including Alzheimer's disease (AD) and Parkinson's disease (PD). | 4 | Jin Z (2026) | Anti-Neuroinflammation Activity of Essential Oils and Fatty Acids. |
| Rosemary Cognitive Performance Randomized Trial | Current pharmacological interventions, such as NSAIDs and corticosteroids, are limited by systemic toxicity and insufficient efficacy in targeting chronic neuroinflammatory processes. | 4 | Jin Z (2026) | Anti-Neuroinflammation Activity of Essential Oils and Fatty Acids. |
Source documents